Massachusetts Financial Services
SGMO

Massachusetts Financial Services’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Massachusetts Financial Services’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-193,762
Closed -$168K – 922
2024
Q3 		$168K Sell
193,762
-4,692
-2% -$3.44K ﹤0.01% 841
2024
Q2 		$71.1K Buy
198,454
+6,662
+3% +$3.6K ﹤0.01% 859
2024
Q1 		$129K Sell
191,792
-424
-0.2% -$308 ﹤0.01% 839
2023
Q4 		$104K Sell
192,216
-6,072
-3% -$2.8K ﹤0.01% 833
2023
Q3 		$119K Sell
198,288
-7,597
-4% -$8.13K ﹤0.01% 836
2023
Q2 		$268K Sell
205,885
-4,850
-2% -$6.63K ﹤0.01% 803
2023
Q1 		$371K Sell
210,735
-5,958
-3% -$17K ﹤0.01% 817
2022
Q4 		$680K Sell
216,693
-201,869
-48% -$783K ﹤0.01% 801
2022
Q3 		$2.05M Buy
+418,562
New +$2.15M ﹤0.01% 720
2022
Q2 		– Sell
-122,387
Closed -$711K – 881
2022
Q1 		$711K Buy
122,387
+1,254
+1% +$7.46K ﹤0.01% 810
2021
Q4 		$908K Buy
121,133
+65,998
+120% +$573K ﹤0.01% 821
2021
Q3 		$497K Buy
+55,135
New +$545K ﹤0.01% 875

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Massachusetts Financial Services's SGMO Position: Q4 2024 in Review

Massachusetts Financial Services sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2024, closing a stake of 193,762 shares — an estimated $168K sold.

Massachusetts Financial Services first reported a position in SGMO in Q3 2021 and held it in 12 quarters. The position peaked at $2.05M in Q3 2022. 128 funds tracked by Wall St. Rank hold SGMO as of Q4 2024.

  • Massachusetts Financial Services reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2024 after selling out during the quarter.
  • Massachusetts Financial Services sold 193,762 SANGAMO THERAPEUTICS INC shares in Q4 2024, an estimated $168K.
  • Massachusetts Financial Services first reported a position in SANGAMO THERAPEUTICS INC in Q3 2021 and held it in 12 quarters.
  • Massachusetts Financial Services's SANGAMO THERAPEUTICS INC position peaked at $2.05M in Q3 2022.
  • 128 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2024.

Based on Massachusetts Financial Services's 13F filing for Q4 2024, filed 12 Feb 2025.